Delivery Order SPE2DB24D2010-SPE2DB24FZWV3

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is a Delivery Order valued at $1,008.09 for the supply of Lantus 100 unit/mL vial (10 mL). The contract has an ultimate completion date of September 17, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,637.36 Firm Fixed Price Delivery Order is for the provision of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication. The contract has an Ultimate Completion Date of April 23, 2024 and was awarded on April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with federal agencies - one...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,001.43, is for the delivery of Lantus 100 unit/mL vial, 10 mL, a specialty medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus 100 unit/mL vial (10 mL). The $1,060.42 contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,533.68 firm fixed-price contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a specialty medication used in the treatment of diabetes. The contract has an ultimate completion date of June 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,584.70 delivery order is for LANTUS 100 UNIT/ML VIAL 10ML and has a completion date of July 18, 2023. The contract is a firm fixed-price, with no set-aside designation indicated. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus 100 unit/mL vial, 10mL, a medication used to treat diabetes. The contract has a ceiling value of $1,223.39 and runs through December 18, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.40 contract is a Firm Fixed Price Delivery Order for Lantus 100 Unit/ML Vial 10ML, a specialty medication used for treating diabetes. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.06 delivery order contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,351.59 and a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZWV3
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,709.98 firm-fixed-price contract is for the provision of Lantus 100 Unit/ML Vial 10ML, a prescription medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for delivering a wide range of pharmaceutical and medical supplies to support various federal healthcare programs and facilities. This contract award is not designated as a set-aside.

Generated 11/7/24, 9:32 AM